Top compounds associated with response to C1orf162


Feature Type Standardized
Nominal ANOVA
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.3 9e-19
mRNA ATRA CTRPv2 pan-cancer AAC 0.28 4e-16
mRNA linifanib GDSC1000 pan-cancer AAC 0.27 3e-13
mRNA AC220 GDSC1000 pan-cancer AAC 0.26 1e-12
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 3e-10
mRNA Sorafenib CCLE pan-cancer AAC 0.3 6e-10
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 2e-09
mRNA PD318088 CTRPv2 pan-cancer AAC 0.2 2e-08
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.2 2e-08
mRNA AZD6244 CCLE pan-cancer AAC 0.25 4e-08
Download CSV